nelfinavir mesylate
Term · Oncology and biomedicine · MLC-T-ONC-005725
A drug that interferes with the ability of a virus to make copies of itself.
The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents.
| Identifier | MLC-T-ONC-005725 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-005725",
"term": "nelfinavir mesylate",
"field": "Oncology and biomedicine",
"definitions": [
"A drug that interferes with the ability of a virus to make copies of itself.",
"The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nelfinavir-mesylate/"
}
Record 11,679 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.